查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1611232

血液檢測市場規模、佔有率、趨勢分析報告：按測試類型、地區、細分市場預測，2025-2030 年

Blood Testing Market Size, Share & Trends Analysis Report By Test Type (Glucose, Lipid, COVID-19, A1C, CRP, Vitamin-D, ALT, AST, Thyroid Stimulating Hormone, PSA, Cortisol), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

血液檢測市場的成長和趨勢

Grand View Research, Inc.最新報告顯示，預計2030年全球血液檢測市場規模將達到1,605億美元，2025年至2030年複合年成長率為8.83%。該市場的成長歸因於多種因素，包括對傳染源識別的需求不斷增加以及政府和監管機構醫療保健支出的增加。此外，糖尿病、COVID-19 和心血管疾病等感染疾病等傳染病率的上升預計將推動市場成長。例如，根據美國疾病管制與預防中心的數據，2022年美國約有3,730萬人被診斷出患有糖尿病，佔總人口的11.3%。

糖尿病盛行率的不斷上升創造了對血液檢測的巨大需求，並促進了市場的成長。此外，用於血液檢測的產品的技術進步正在推動市場的成長。攜帶式血糖儀的出現使患者可以隨時隨地方便地進行常規檢查，這有助於市場的成長。此外，糖尿病患者在手術前進行糖尿病監測非常重要，這進一步推動了對這些產品的需求。預計新產品的採用將在預測期內推動市場成長。

例如，2022 年 5 月，Labcorp 透過 Labcorp OnDemand 推出了一款家用採集套件。該套件允許個人從少量血液樣本中測量糖化血紅蛋白 (HbA1c) 值並監測血糖水平。美國紅十字會、紐約血液中心、美國血液中心、武裝部隊血液計畫、AABB 和美國血液中心等領先組織在提供有關血漿採集和捐贈的資訊方面發揮著重要作用。捐血的增加預計將進一步推動對移植前和移植後程序中使用的檢測產品的需求，從而促進市場成長。

血液檢測市場報告亮點

  • 2024 年，血糖測試領域佔據最大的收益佔有率。支持這一細分市場成長的是 I 型和 II 型糖尿病盛行率的增加以及與遺傳性糖尿病相關的病例數量的增加。
  • 技術的不斷進步促進了創新血液檢測方法和設備的發展。就地檢驗、穿戴式裝置和改進的實驗室測試技術等進步正在推動市場成長。
  • 北美地區在 2024 年佔據最大的收益佔有率，預計在預測期內將保持其地位，而亞太地區預計將在 2025 年至 2030 年期間出現顯著成長。
  • 該行業的主要參與企業正專注於產品發布和地理擴張，以維持其影響力。例如，2023 年 3 月，蘋果在非侵入性血糖監測技術的開發方面取得了顯著進展，允許患有糖尿病和其他疾病的個人血糖值，而無需進行皮膚刺痛或傳統的血液檢測方法。可以測量它。
  • 2022 年 6 月，阿波羅癌症中心與 Datar Cancer Genetics 合作，宣布進行一項血液檢測，可檢測無症狀族群的早期乳癌。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章 市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 工業分析工具
    • 波特五力分析
    • PESTEL分析

第4章 採血點經營分析

  • 血液檢測市場：採血地點儀表板
  • 血液檢測市場：採血地點變化分析
  • 血液檢測市場（依採集地點、收益）
  • 血糖測試
    • 2018-2030年血糖檢測市場
  • A1C測試
    • A1C測試市場，2018-2030
  • 直接低密度脂蛋白測試
    • 直接 LDL 檢測市場，2018-2030 年
  • 血脂檢查
    • 血脂檢查市場，2018-2030
  • 攝護腺特異性抗原檢測
    • 前列腺特異性抗原檢測市場，2018-2030
  • COVID-19 測試
    • COVID-19 測試市場，2018-2030
  • 尿素氮檢查
    • BUN 測試市場，2018-2030
  • 維生素D測試
    • 維生素 D 測試市場，2018-2030
  • 甲狀腺刺激素（TSH）測試
    • 甲狀腺刺激素（TSH）檢測市場，2018-2030
  • 血清尼古丁/可替寧測試
    • 血清尼古丁/可替寧測試市場，2018-2030
  • 高靈敏度CRP測試
    • 高靈敏度CRP檢測市場，2018-2030年
  • 睪酮測試
    • 測試類固醇測試市場，2018-2030
  • 丙氨酸轉氨酶測試
    • ALT 測試市場，2018-2030
  • 皮質醇測試
    • 皮質醇測試市場，2018-2030
  • 肌酸酐測試
    • 肌酸酐檢測市場，2018-2030
  • 穀草轉氨酶測試
    • AST 測試市場，2018-2030
  • 其他血液檢查
    • 其他血液檢測市場，2018-2030

第5章區域業務分析

  • 2024 年和 2030 年按地區分類的血液檢測市場佔有率
  • 北美洲
    • 北美血液檢測市場，2018-2030
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 歐洲血液檢測市場，2018-2030
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麥
    • 俄羅斯
  • 亞太地區
    • 亞太血液檢測市場，2018-2030
    • 中國
    • 印度
    • 日本
    • 泰國
    • 韓國
    • 新加坡
  • 拉丁美洲
    • 拉丁美洲血液檢測市場，2018-2030
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 中東和非洲血液檢測市場，2018-2030
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 科威特

第6章 競爭狀況

  • 公司分類
  • 策略規劃
  • 2024 年企業市場佔有率分析
  • 公司簡介/上市公司
    • Abbott
    • bioMerieux
    • Quest Diagnostics Incorporated
    • Biomerica, Inc
    • BD
    • QIAGEN Siemens Healthineers AG
    • Danaher Corporation
    • Trinity BIoTech Plc
Product Code: 978-1-68038-897-8

Blood Testing Market Growth & Trends:

The global blood testing market size is estimated to reach USD 160.50 billion by 2030, registering a CAGR of 8.83% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is attributable to various factors including the growing demand for the identification of infectious agents and increased healthcare spending by government and regulatory bodies. Furthermore, the rising prevalence of infectious diseases, such as diabetes, COVID-19, and cardiovascular diseases, is anticipated to drive market growth. For instance, according to the CDC in 2022, approximately 37.3 million people were diagnosed with diabetes in the United States, accounting for 11.3 % of the population.

This increasing prevalence of diabetes creates a significant demand for blood tests, thus contributing to the growth of the market. Furthermore, technological advancement in the products used for blood testing fuels the growth of the market. The availability of portable glucose meters that enable patients to perform routine checkups conveniently and anywhere has contributed to an expansion of the market. In addition, the monitoring of diabetes is crucial prior to any surgical intervention for patients with diabetes, which further drives the demand for these products. The introduction of new products is anticipated to fuel market growth over the projection period.

For instance, in May 2022, Labcorp introduced an at-home collection kit with Labcorp OnDemand, which allows individuals to measure their hemoglobin A1c (HbA1c) levels from a small blood sample to monitor their sugar levels. Key organizations, such as the American Red Cross, the New York Blood Center, America's Blood Centers, Armed Services Blood Program, AABB, and Blood Centers of America, play a crucial role in providing information on plasma collection and delivery. The rise in blood donations is expected to further drive the demand for testing products used in pre-transplant and post-transplant procedures, thereby boosting market growth.

Blood Testing Market Report Highlights:

  • The glucose testing segment held the largest revenue share in 2024. The segment growth is supported by the increasing prevalence of both type I and type II diabetes, along with the growing number of cases related to hereditary diabetes
  • Continuous advancements in technology have led to the development of innovative blood testing methods and devices. These advancements, such as point-of-care testing, wearable devices, and improved laboratory testing techniques, drive market growth.
  • North America held the largest revenue share in 2024 and is expected to maintain its position throughout the forecast period; however, Asia Pacific is expected to grow at a significant rate from 2025 to 2030
  • Key players operating are focusing on product launches and geographical expansion to maintain their presence. For instance, in March 2023, Apple made notable progress in the development of non-invasive blood glucose monitoring technology, enabling individuals with diabetes and other conditions to measure their blood glucose levels without the need for skin pricks or traditional blood testing methods
  • In June 2022, Apollo Cancer Centers, in collaboration with Datar Cancer Genetics, introduced a blood test capable of detecting early-stage breast cancers in asymptomatic individuals.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Information Analysis
    • 1.2.2. Market Formulation & Data Visualization
    • 1.2.3. Data Validation & Publishing
  • 1.3. Research Assumptions
  • 1.4. Information Procurement
    • 1.4.1. Primary Research
  • 1.5. Information or Data Analysis
  • 1.6. Market Formulation & Validation
  • 1.7. Market Model
  • 1.8. Global Market: CAGR Calculation
  • 1.9. Objective
    • 1.9.1. Objective 1
    • 1.9.2. Objective2

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing prevalence of target disease
      • 3.2.1.2. Growing demand for point-of-care tests
      • 3.2.1.3. Implementation of favorable government initiatives & external funding for R&D activities
      • 3.2.1.4. Introduction of CLIA waived tests
      • 3.2.1.5. Rising demand for early disease detection
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Stringent regulatory and reimbursement policies
      • 3.2.2.2. Limitations associated with blood testing
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis

Chapter 4. Collection Site Business Analysis

  • 4.1. Blood Testing Market: Collection Site Dashboard
  • 4.2. Blood Testing Market: Collection Site Movement Analysis
  • 4.3. Blood Testing Market by Collection Site, Revenue
  • 4.4. Glucose Testing
    • 4.4.1. Glucose Testing Market, 2018 - 2030 (USD Million)
  • 4.5. A1C Testing
    • 4.5.1. A1C Testing Market, 2018 - 2030 (USD Million)
  • 4.6. Direct LDL Testing
    • 4.6.1. Direct LDL Testing Market, 2018 - 2030 (USD Million)
  • 4.7. Lipid Panel Testing
    • 4.7.1. Lipid Panel Testing Market, 2018 - 2030 (USD Million)
  • 4.8. Prostate Specific Antigen Testing
    • 4.8.1. Prostate Specific Antigen Testing Market, 2018 - 2030 (USD Million)
  • 4.9. COVID-19 Testing
    • 4.9.1. COVID-19 Testing Market, 2018 - 2030 (USD Million)
  • 4.10. BUN Testing
    • 4.10.1. BUN Testing Market, 2018 - 2030 (USD Million)
  • 4.11. Vitamin D Testing
    • 4.11.1. Vitamin D Testing Market, 2018 - 2030 (USD Million)
  • 4.12. Thyroid Stimulating Hormone (TSH) Testing
    • 4.12.1. Thyroid Stimulating Hormone (TSH) Testing Market, 2018 - 2030 (USD Million)
  • 4.13. Serum Nicotine/Cotinine Testing
    • 4.13.1. Serum Nicotine/Cotinine Testing Market, 2018 - 2030 (USD Million)
  • 4.14. High Sensitivity CRP Testing
    • 4.14.1. High Sensitivity CRP Testing Market, 2018 - 2030 (USD Million)
  • 4.15. Testosterone Testing
    • 4.15.1. Testosterone Testing Market, 2018 - 2030 (USD Million)
  • 4.16. ALT Testing
    • 4.16.1. ALT Testing Market, 2018 - 2030 (USD Million)
  • 4.17. Cortisol Testing
    • 4.17.1. Cortisol Testing Market, 2018 - 2030 (USD Million)
  • 4.18. Creatinine Testing
    • 4.18.1. Creatinine Testing Market, 2018 - 2030 (USD Million)
  • 4.19. AST Testing
    • 4.19.1. AST Testing Market, 2018 - 2030 (USD Million)
  • 4.20. Other Blood Tests
    • 4.20.1. Other Blood Tests Market, 2018 - 2030 (USD Million)

Chapter 5. Regional Business Analysis

  • 5.1. Blood Testing Market Share By Region, 2024 & 2030
  • 5.2. North America
    • 5.2.1. North America Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.2.2. U.S.
      • 5.2.2.1. Key Country Dynamics
      • 5.2.2.2. Competitive Scenario
      • 5.2.2.3. Regulatory Framework
      • 5.2.2.4. U.S. Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.2.3. Canada
      • 5.2.3.1. Key Country Dynamics
      • 5.2.3.2. Competitive Scenario
      • 5.2.3.3. Regulatory Framework
      • 5.2.3.4. Canada Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.2.4. Mexico
      • 5.2.4.1. Key Country Dynamics
      • 5.2.4.2. Competitive Scenario
      • 5.2.4.3. Regulatory Framework
      • 5.2.4.4. Mexico Blood Testing Market, 2018 - 2030 (USD Million)
  • 5.3. Europe
    • 5.3.1. Europe Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.3.2. UK
      • 5.3.2.1. Key Country Dynamics
      • 5.3.2.2. Competitive Scenario
      • 5.3.2.3. Regulatory Framework
      • 5.3.2.4. UK Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.3.3. Germany
      • 5.3.3.1. Key Country Dynamics
      • 5.3.3.2. Competitive Scenario
      • 5.3.3.3. Regulatory Framework
      • 5.3.3.4. Germany Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.3.4. France
      • 5.3.4.1. Key Country Dynamics
      • 5.3.4.2. Competitive Scenario
      • 5.3.4.3. Regulatory Framework
      • 5.3.4.4. France Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.3.5. Italy
      • 5.3.5.1. Key Country Dynamics
      • 5.3.5.2. Competitive Scenario
      • 5.3.5.3. Regulatory Framework
      • 5.3.5.4. Italy Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.3.6. Spain
      • 5.3.6.1. Key Country Dynamics
      • 5.3.6.2. Competitive Scenario
      • 5.3.6.3. Regulatory Framework
      • 5.3.6.4. Spain Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.3.7. Sweden
      • 5.3.7.1. Key Country Dynamics
      • 5.3.7.2. Competitive Scenario
      • 5.3.7.3. Regulatory Framework
      • 5.3.7.4. Sweden Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.3.8. Norway
      • 5.3.8.1. Key Country Dynamics
      • 5.3.8.2. Competitive Scenario
      • 5.3.8.3. Regulatory Framework
      • 5.3.8.4. Norway Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.3.9. Denmark
      • 5.3.9.1. Key Country Dynamics
      • 5.3.9.2. Competitive Scenario
      • 5.3.9.3. Regulatory Framework
      • 5.3.9.4. Denmark Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.3.10. Russia
      • 5.3.10.1. Key Country Dynamics
      • 5.3.10.2. Competitive Scenario
      • 5.3.10.3. Regulatory Framework
      • 5.3.10.4. Russia Blood Testing Market, 2018 - 2030 (USD Million)
  • 5.4. Asia Pacific
    • 5.4.1. Asia Pacific Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.4.2. China
      • 5.4.2.1. Key Country Dynamics
      • 5.4.2.2. Competitive Scenario
      • 5.4.2.3. Regulatory Framework
      • 5.4.2.4. China Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.4.3. India
      • 5.4.3.1. Key Country Dynamics
      • 5.4.3.2. Competitive Scenario
      • 5.4.3.3. Regulatory Framework
      • 5.4.3.4. India Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.4.4. Japan
      • 5.4.4.1. Key Country Dynamics
      • 5.4.4.2. Competitive Scenario
      • 5.4.4.3. Regulatory Framework
      • 5.4.4.4. Japan Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.4.5. Thailand
      • 5.4.5.1. Key Country Dynamics
      • 5.4.5.2. Competitive Scenario
      • 5.4.5.3. Regulatory Framework
      • 5.4.5.4. Thailand Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.4.6. South Korea
      • 5.4.6.1. Key Country Dynamics
      • 5.4.6.2. Competitive Scenario
      • 5.4.6.3. Regulatory Framework
      • 5.4.6.4. South Korea Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.4.7. Singapore
      • 5.4.7.1. Key Country Dynamics
      • 5.4.7.2. Competitive Scenario
      • 5.4.7.3. Regulatory Framework
      • 5.4.7.4. Singapore Blood Testing Market, 2018 - 2030 (USD Million)
  • 5.5. Latin America
    • 5.5.1. Latin America Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.5.2. Brazil
      • 5.5.2.1. Key Country Dynamics
      • 5.5.2.2. Competitive Scenario
      • 5.5.2.3. Regulatory Framework
      • 5.5.2.4. Brazil Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.5.3. Argentina
      • 5.5.3.1. Key Country Dynamics
      • 5.5.3.2. Competitive Scenario
      • 5.5.3.3. Regulatory Framework
      • 5.5.3.4. Argentina Blood Testing Market, 2018 - 2030 (USD Million)
  • 5.6. MEA
    • 5.6.1. MEA Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.6.2. Saudi Arabia
      • 5.6.2.1. Key Country Dynamics
      • 5.6.2.2. Competitive Scenario
      • 5.6.2.3. Regulatory Framework
      • 5.6.2.4. Saudi Arabia Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.6.3. South Africa
      • 5.6.3.1. Key Country Dynamics
      • 5.6.3.2. Competitive Scenario
      • 5.6.3.3. Regulatory Framework
      • 5.6.3.4. South Africa Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.6.4. UAE
      • 5.6.4.1. Key Country Dynamics
      • 5.6.4.2. Competitive Scenario
      • 5.6.4.3. Regulatory Framework
      • 5.6.4.4. UAE Blood Testing Market, 2018 - 2030 (USD Million)
    • 5.6.5. Kuwait
      • 5.6.5.1. Key Country Dynamics
      • 5.6.5.2. Competitive Scenario
      • 5.6.5.3. Regulatory Framework
      • 5.6.5.4. Kuwait Blood Testing Market, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Company Categorization
  • 6.2. Strategy Mapping
  • 6.3. Company Market Share Analysis, 2024
  • 6.4. Company Profiles/Listing
    • 6.4.1. Abbott
      • 6.4.1.1. Overview
      • 6.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.1.3. Collection Site Benchmarking
      • 6.4.1.4. Strategic Initiatives
    • 6.4.2. bioMerieux
      • 6.4.2.1. Overview
      • 6.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.2.3. Collection Site Benchmarking
      • 6.4.2.4. Strategic Initiatives
    • 6.4.3. Quest Diagnostics Incorporated
      • 6.4.3.1. Overview
      • 6.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.3.3. Collection Site Benchmarking
      • 6.4.3.4. Strategic Initiatives
    • 6.4.4. Biomerica, Inc
      • 6.4.4.1. Overview
      • 6.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.4.3. Collection Site Benchmarking
      • 6.4.4.4. Strategic Initiatives
    • 6.4.5. BD
      • 6.4.5.1. Overview
      • 6.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.5.3. Collection Site Benchmarking
      • 6.4.5.4. Strategic Initiatives
    • 6.4.6. QIAGEN Siemens Healthineers AG
      • 6.4.6.1. Overview
      • 6.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.6.3. Collection Site Benchmarking
      • 6.4.6.4. Strategic Initiatives
    • 6.4.7. Danaher Corporation
      • 6.4.7.1. Overview
      • 6.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.7.3. Collection Site Benchmarking
      • 6.4.7.4. Strategic Initiatives
    • 6.4.8. Trinity Biotech Plc
      • 6.4.8.1. Overview
      • 6.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.8.3. Collection Site Benchmarking
      • 6.4.8.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Global Blood Testing Market, By Region, 2018 - 2030 (USD Million)
  • Table 4 Global Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 5 North America Blood Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 6 North America Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 7 U.S. Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 8 Canada Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 9 Mexico Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 10 Europe Blood Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 11 Europe Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 12 France Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 13 Germany Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 14 UK Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 15 Spain Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 16 France Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 17 Italy Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 18 Sweden Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 19 Norway Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 20 Denmark Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 21 Asia Pacific Blood Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 22 Asia Pacific Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 23 Japan Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 24 China Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 25 India Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 26 South Korea Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 27 Australia Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 28 Thailand Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 29 Latin America Blood Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 30 Latin America Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 31 Brazil Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 32 Argentina Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 33 MEA Blood Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 34 MEA Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 35 South Africa Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 36 Saudi Arabia Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 37 UAE Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 38 Kuwait Blood Testing Market, By Test Type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Blood Testing Market Segmentation
  • Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 11 Penetration & Growth Prospect Mapping
  • Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 Blood testing market: Testing type outlook and key takeaways
  • Fig. 15 Blood testing market: Testing type movement analysis & market share 2024 & 2030
  • Fig. 16 Glucose testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 A1C testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Direct LDL testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Lipid panel testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 PSA testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 COVID-19 testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 BUN testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Vitamin D testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 TSH testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Serum nicotine/cotinine testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 CRP testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Testosterone testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 ALT testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Cortisol testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Creatinine testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 AST testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Other blood testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Regional Outlook, 2024 & 2030
  • Fig. 34 Regional Market Dashboard
  • Fig. 35 Regional Market Place: Key Takeaways
  • Fig. 36 North America, SWOT Analysis
  • Fig. 37 Europe, SWOT Analysis
  • Fig. 38 Asia Pacific, SWOT Analysis
  • Fig. 39 Latin America, SWOT Analysis
  • Fig. 40 MEA, SWOT Analysis
  • Fig. 41 North America
  • Fig. 42 North America Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 43 U.S.
  • Fig. 44 U.S. Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Canada
  • Fig. 46 Canada Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Mexico
  • Fig. 48 Mexico Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Europe
  • Fig. 50 Europe Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 51 UK
  • Fig. 52 UK Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Germany
  • Fig. 54 Germany Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Italy
  • Fig. 56 Italy Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 57 France
  • Fig. 58 France Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Spain
  • Fig. 60 Spain Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Sweden
  • Fig. 62 Sweden Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Norway
  • Fig. 64 Norway Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Denmark
  • Fig. 66 Denmark Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Asia Pacific
  • Fig. 68 Asia-Pacific Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 69 China
  • Fig. 70 China Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 71 India
  • Fig. 72 India Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 73 Japan
  • Fig. 74 Japan Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Australia
  • Fig. 76 Australia Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 77 Thailand
  • Fig. 78 Thailand Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 79 South Korea
  • Fig. 80 South Korea Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 81 Latin America
  • Fig. 82 Latin America Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 83 Brazil
  • Fig. 84 Brazil Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 85 Argentina
  • Fig. 86 Argentina Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 87 MEA
  • Fig. 88 MEA Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 89 UAE
  • Fig. 90 UAE Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 91 South Africa
  • Fig. 92 South Africa Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 93 Saudi Arabia
  • Fig. 94 Saudi Arabia Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 95 Kuwait
  • Fig. 96 Kuwait Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 97 Strategy Mapping